Ticker: ATHA

Company: Athira Pharma, Inc.

Person: Litton Mark James, director, officer

Transaction date: Sept. 3, 2024

Reporting date: Sept. 5, 2024

Average share price: -0.1902800641368252

Sold 14968.0 shares for 2848.11